Corpus Intelligence IC Memo — COXHEALTH 2026-04-26 08:08 UTC
IC Memo — COXHEALTH
Investment Committee Memorandum | MO | 791 beds | Grade C | EBITDA uplift $101.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

COXHEALTH

CCN 260040 | GREENE, MO | 791 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

COXHEALTH is a 791-bed large academic medical center in GREENE, MO with $1.38B in net patient revenue and a -7.6% operating margin. The hospital serves a payer mix of 19.2% Medicare, 15.7% Medicaid, and 65.1% commercial.

Thesis: Undervalued. Our ML models identify $101.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -7.6% to -0.3% (+736bps).

Net Revenue HCRIS$1.38B
Current EBITDA COMPUTED$-105.3M
Operating Margin COMPUTED-7.6%
Occupancy HCRIS59.1%
Revenue / Bed COMPUTED$1.7M
Net-to-Gross HCRIS28.6%
Distress Probability ML49.9%

2. Market Context & Competitive Position

138
MO Hospitals
-6.2%
State Median Margin
10
Comparable Hospitals

MO has 138 Medicare-certified hospitals with a median operating margin of -6.2%. The target's margin of -7.6% places it below the state median. Among 10 size-comparable peers (396-1582 beds), the median margin is -0.6%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (396-1582), prioritizing same-state peers. 10 hospitals in the comp set.

HospitalStateBedsRevenueMargin
COXHEALTH (Target)MO791$1.38B-7.6%
BARNES-JEWISH HOSPITALMO1259$2.42B-2.0%
MERCY HOSPITAL - ST. LOUISMO815$1.39B13.5%
UNIV OF MISSOURI HEALTH CAREMO521$1.36B-2.0%
MERCY HOSPITAL SPRINGFIELDMO617$1.05B6.1%
ST. LOUIS CHILDRENS HOSPITALMO445$886.1M6.4%
SAINT LUKES HOSPITAL OF KANSASMO466$883.5M-12.4%
SSM HEALTH ST. MARYS HOSPITAL MO501$792.8M-0.0%
MISSOURI BAPTIST MEDICAL CENTEMO402$716.0M2.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $101.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$28.9M+210bp18mo
Cost to Collect4.5%2.5%$27.6M+200bp12mo
Denial Rate Reduction12.0%6.5%$27.3M+198bp12mo
A/R Days Reduction5200.0%3800.0%$16.8M+122bp9mo
Clean Claim Rate88.0%96.0%$882K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$28.9M
Cost to Collect
$27.6M
Denial Rate Reduction
$27.3M
A/R Days Reduction
$16.8M
Clean Claim Rate
$882K
Total EBITDA Uplift$101.4M
Current EBITDA$-105.3M
+ RCM Uplift+$101.4M
Pro Forma EBITDA$-3.9M
Current Margin-7.6%
Pro Forma Margin-0.3%
WC Released (1x)$52.9M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-162.0M$319.5M0.00x-100.0%
Base (11x exit)10.0x11.0x$-162.0M$298.8M0.00x-100.0%
Bull Case9.0x11.0x$-145.8M$580.9M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-145.8M$590.6M0.00x-100.0%
Bear Case11.0x10.0x$-178.2M$-135.0M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-178.2M$-206.4M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 10 hospitals with 396-1582 beds
  • Same-state prioritization (n=11)
  • Comp margins: P25=-2.0% / P50=-0.6% / P75=5.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.